# A Study to Evaluate Absorption, Distribution and Elimination of Mirabegron After Oral Administration to Non-elderly Healthy Chinese Subjects

> **NCT01747564** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 24 (actual)

## Conditions studied

- Healthy Subjects
- Plasma Concentration of Mirabegron

## Interventions

- **DRUG:** YM178 (mirabegron)

## Key facts

- **NCT ID:** NCT01747564
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01747564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01747564, "A Study to Evaluate Absorption, Distribution and Elimination of Mirabegron After Oral Administration to Non-elderly Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01747564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*